Diabetologia

, Volume 36, Issue 10, pp 1071–1078 | Cite as

The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy

  • M. -A. Gall
  • F. S. Nielsen
  • U. M. Smidt
  • H. -H. Parving
Article

Summary

We evaluated the impact of some putative progression promoters on kidney function in albuminuric Type 2 (non-insulin-dependent) diabetic patients with biopsyproven diabetic glomerulosclerosis. Twenty-six patients (1 female) with a mean age of 52 (standard error 2) years and a known mean duration of diabetes of 9 (1) years were followed-up prospectively for a mean of 5.2 (range 1.0–7.0) years. Twenty-one patients received antihypertensive treatment. During the observation period the glomerular filtration rate decreased from 83 (24–146) to 58 (2–145) ml·min−1·1.73 m−2 (mean (range)) (p<0.001). The mean rate of decline in glomerular filtration rate was 5.7 (−3.5 to 22.0) ml/min per year. Albuminuria increased from 1.2 (0.3–7.2) to 2.3 (0.4–8.0) g/24 h (geometric mean (range)) (p<0.001). Arterial blood pressure remained unchanged: 162/93 (SE 4/3) and 161/89 (4/2) mm Hg. Univariate analysis showed the rate of decline in glomerular filtration rate to correlate with systolic blood pressure (r=0.71,p<0.001), mean blood pressure (r=0.56,p<0.005), albuminuria (r=0.58,p<0.005) and the initial glomerular filtration rate (r=−0.49,p<0.02). The rate of decline in glomerular filtration rate did not correlate significantly with dietary protein intake, total cholesterol, high-density lipoprotein cholesterol or HbA1c. Three patients died from uraemia and four patients died from cardiovascular disease. Two patients required renal replacement therapy at the end of the observation period. Our prospective observational study revealed that one-fifth of the patients developed end-stage renal failure during the 5-year observation period. The decline in glomerular filtration rate varied considerably between patients. Increase in arterial blood pressure to a hypertensive level is an early feature of diabetic nephropathy. Elevated systolic blood pressure accelerates the progression of diabetic nephropathy in Type 2 diabetic patients.

Key words

Type 2 (non-insulin-dependent) diabetes mellitus diabetic nephropathy kidney function 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Eggers PW (1988) Effect of transplantation on the medicare end-stage renal disease program. N. Engl J Med 381: 223–229.Google Scholar
  2. 2.
    Rettig B, Teutsch SM (1984) The incidence of end-stage renal disease in type I and type II diabetes mellitus. Diabetic Nephropathy 3: 26–27.Google Scholar
  3. 3.
    Grenfell A., Bewick M., Parsons V., Snowden S, Taube D, Watkins PJ (1988) Non-insulin-dependent diabetes and renal replacement therapy. Diabetic Med 5: 172–176PubMedGoogle Scholar
  4. 4.
    Ballard DJ, Humphrey LL, Melton J III et al. (1988) Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 37: 405–412PubMedGoogle Scholar
  5. 5.
    Striker GE, Agodoa LL, Held P, Doi T, Conti F, Striker LJ (1991) Kidney disease of diabetes mellitus (diabetic nephropathy): perspectives in the United States. J. Diab Compl 5: 51–52Google Scholar
  6. 6.
    Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H (1990) A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: causes and death rates. Diabetologia 33: 538–541PubMedGoogle Scholar
  7. 7.
    Morrish NJ, Stevens LK, Head, J, Fuller JH, Jarrett RJ, Keen H (1990) A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: associated risk factors. Diabetologia 33: 542–548PubMedGoogle Scholar
  8. 8.
    Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC (1988) Effect of proteinuria on mortality in NIDDM. Diabetes 37: 1499–1504PubMedGoogle Scholar
  9. 9.
    Mogensen CE (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 285: 685–688PubMedGoogle Scholar
  10. 10.
    Parving H-H, Smidt UM, Friisberg B, Bennevie-Nielsen V, Andersen AR (1981) A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 20: 457–461CrossRefPubMedGoogle Scholar
  11. 11.
    Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ 294: 1143–1147Google Scholar
  12. 12.
    Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M (1986) Beneficial effects of angiotensin coverting enzyme inhibition on renal function in patients with diabetic nephropathy. BMJ 293: 471–474PubMedGoogle Scholar
  13. 13.
    Parving H-H (1991) Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 14: 260–269PubMedGoogle Scholar
  14. 14.
    Björck S, Mulec H, Johnsen SA, Nordén G, Aurell M (1992) Renal protective effect of enalapril in diabetic nephropathy. BMJ 304: 339–343PubMedGoogle Scholar
  15. 15.
    Zeller K, Whittaker E, Sullivan L, Roskin P, Jacobson HR (1991) Effect of restricting dietary protein on progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 324: 78–84PubMedGoogle Scholar
  16. 16.
    Walker JD, Bending JJ, Dodds RA et al. (1989) Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet II: 1411–1415Google Scholar
  17. 17.
    Hasslacher C, Stech W, Wahl P, Ritz E (1985) Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent_ diabetes. Diabetologia 28: 6–11CrossRefPubMedGoogle Scholar
  18. 18.
    Viberti GC, Bilous RW, Mackintosh D, Bending JJ, Keen H (1983) Long-term correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes. BMJ 286: 598–602PubMedGoogle Scholar
  19. 19.
    Mulec H, Johnson S-A, Björck S (1990) Relation between serum cholesterol and diabetic nephropathy. Lancet 335: 1537–1538 (Letter)CrossRefPubMedGoogle Scholar
  20. 20.
    Gall M-A, Rossing P, Skøtt P et al. (1991) Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 34: 655–661CrossRefPubMedGoogle Scholar
  21. 21.
    Parving H-H, Gall M-A, Skøtt P, et al. (1992) Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int 41: 758–762PubMedGoogle Scholar
  22. 22.
    Skøtt P, Hommel E, Bruun NE, Arnold-Larsen S, Parving H-H (1988) Effects of acetazolamide on kidney function in type 1 (insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 31: 806–810CrossRefPubMedGoogle Scholar
  23. 23.
    Hother-Nielsen O, Faber O, Sørensen NS, Beck-Nielsen H (1988) Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care 11: 531–537PubMedGoogle Scholar
  24. 24.
    Brøchner-Mortensen J, Giese J Rossing N (1969) Renal inulin clearance versus total plasma clearnace of51Cr-EDTA. Scand J Clin Lab Invest 26: 5–11Google Scholar
  25. 25.
    Christensen C, Ørskov C (1984) Rapid screening PEG radioimmunoassay for quantitation of pathological microalbuminuria. Diabetic Nephropathy 3: 92–94Google Scholar
  26. 26.
    Maroni BJ, Steinman TI, Mitch WE (1985) A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27: 58–65PubMedGoogle Scholar
  27. 27.
    Isaksson B (1982) Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr 33: 4–5Google Scholar
  28. 28.
    Mortensen HB (1989) Quantitative determination of haemoglobin A1c by thin-layer isoelectric focusing. Scand J Clin Lab Invest 49:537–544Google Scholar
  29. 29.
    Ullmann R, Bonitz K (1976) Vollmechanisierte kinetische Messung von Kreatinin. Med Labor Bd 29: 137–145Google Scholar
  30. 30.
    Amoah E, Glickman JL, Malchoff CD, Steergill BC, Kaiser DL, Bolton WK (1988) Clinical identification of non-diabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction. Am J Nephrol 8: 204–211PubMedGoogle Scholar
  31. 31.
    Taft JL, Billson VR, Nankervis A Kincaid-Smith P, Martin FJR (1990) A clinical-histological study of individuals with diabetes mellitus and proteinuria. Diabetic Med 7: 215–221PubMedGoogle Scholar
  32. 32.
    Fabre J, Balant LP, Dayer PG, Hilke MF, Vernet AT (1982) The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int 21: 730–738PubMedGoogle Scholar
  33. 33.
    Friedman R, Gross JL (1991) Evolution of glomerular filtration rate in proteinuric NIDDM patients. Diabetes Care 14: 355–359PubMedGoogle Scholar
  34. 34.
    Parving H-H, Hommel E, Smidt UM (1988) Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 297: 1086–1091PubMedGoogle Scholar
  35. 35.
    Nelson RG, Newman JM, Knowler WC et al. (1988) Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 31: 730–736CrossRefPubMedGoogle Scholar
  36. 36.
    Jameel N, Pugh JA (1991) Presence of pre-existing hypertension is more important than ethnicity in determining duration of diabetes prior to ESRD in NIDDM. JASN 2: 291 (Abstract)Google Scholar
  37. 37.
    Nelson RG, Kunzelman CL, Pettitt DJ, Saad MF, Bennett PH, Knowler WC (1989) Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 32: 870–876CrossRefPubMedGoogle Scholar
  38. 38.
    Marshall SM, Alberti KGMM (1989) Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Quart J Med 261: 61–71Google Scholar
  39. 39.
    Sasaki A, Horiuchi N, Hasagawa K, Uehara M (1989) Persistent albuminuria as an index of diabetic nephropathy in type 2 diabetic patients in Osaka, Japan — incidence, risk factors, prognosis and causes of death. Diabetes Res Clin Pract 7: 299–306PubMedGoogle Scholar
  40. 40.
    Berkman J, Rifkin H (1973) Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson). Report of a case. Metabolism 22: 715–722CrossRefPubMedGoogle Scholar
  41. 41.
    Hostetter TH, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380.CrossRefPubMedGoogle Scholar
  42. 42.
    Steffes MW, Brown DM, Mauer SM (1978) Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27: 35–41PubMedGoogle Scholar
  43. 43.
    Remuzzi G, Bertani T (1990) Editorial review: is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384–394PubMedGoogle Scholar
  44. 44.
    Jacobson HR (1991) Chronic renal failure: pathophysiology. Lancet 338: 419–423CrossRefPubMedGoogle Scholar
  45. 45.
    Jameel N, Pugh JA, Mitchell BD, Stern MP (1992) Dietary protein intake is not correlated with clinical proteinuria in NIDDM. Diabetes Care 15: 178–183PubMedGoogle Scholar
  46. 46.
    Klahr S (1991) Chronic renal failure: management. Lancet 338: 423–427CrossRefPubMedGoogle Scholar
  47. 47.
    Pettitt DJ, Knowler WC, Lisse JR, Bennett PH (1980) Development of retinopathy and proteinuria in relation to plasma-glucose concentrations in Pima Indians. Lancet II: 1050–1052Google Scholar
  48. 48.
    Kostner GM, Karádi I (1988) Lipoprotein alterations in diabetes mellitus. Diabetologia 31: 717–722CrossRefPubMedGoogle Scholar
  49. 49.
    Moorhead JF, El-Nahas M, Chan MK, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disesea. Lancet II: 1309–1311Google Scholar
  50. 50.
    Kasiske BL, O'Donnell MP, Cleary MP, Keane WF (1988) Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33: 667–672PubMedGoogle Scholar
  51. 51.
    Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF (1988) Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chornic renal failure. Circ Res 62: 367–374PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • M. -A. Gall
    • 1
  • F. S. Nielsen
    • 1
  • U. M. Smidt
    • 1
  • H. -H. Parving
    • 1
  1. 1.Steno Memorial and Hvidöre HospitalKlampenborgDenmark

Personalised recommendations